AC Immune (ACIU) Non-Current Assets (2014 - 2026)

AC Immune (ACIU) has reported Non-Current Assets for 12 consecutive years, with $73.3 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Assets rose 111635.33% year-over-year to $73.3 billion; the TTM figure through Mar 2026 stood at -$47.4 billion (down 18252.19% YoY), while the FY2025 annual figure was -$116.5 billion, down 173275.36% from the prior year.
• Non-Current Assets advanced to $73.3 billion in Q1 2026 per ACIU's latest filing, from -$120.8 billion in the prior quarter.
• Across five years, Non-Current Assets topped out at $73.3 billion in Q1 2026 and bottomed at -$191.7 billion in Q1 2022.
• Historically, Non-Current Assets has averaged -$32.0 billion across 5 years, with a median of $63.5 million in 2023.
• Annual changes were most pronounced in 2023 — Non-Current Assets slumped 234740.01% — and 2026, when it jumped 111635.33%.
• AC Immune's Non-Current Assets stood at $60.0 million in 2022, then plunged by 234740.01% to -$140.9 billion in 2023, then soared by 100.05% to $67.3 million in 2024, then tumbled by 179742.36% to -$120.8 billion in 2025, then jumped by 160.63% to $73.3 billion in 2026.
• Business Quant data shows ACIU's Non-Current Assets at $73.3 billion in Q1 2026, -$120.8 billion in Q4 2025, and $72.3 million in Q3 2025.